abstract |
The present invention relates to (1, 1, 1, 3, 3, 3-hexafluoro-2-hydroxypropan-2-yl)phenyl derivatives having the general formula I, to pharmaceutical compositions comprising the same and to the use of these (1, 1, 1, 3, 3, 3-hexafluoro-2-hydroxypropan-2-yl)phenyl derivatives in the treatment of atherosclerosis. |